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Background: Genetics may partially explain observed heterogeneity in associations between traffic-
related air pollution and incident asthma.
oBjective: Our aim was to investigate the impact of gene variants associated with oxidative stress and 
inflammation on associations between air pollution and incident childhood asthma.
Methods: Traffic-related air pollution, asthma, wheeze, gene variant, and potential confounder data were 
pooled across six birth cohorts. Parents reported physician-diagnosed asthma and wheeze from birth to 
7–8 years of age (confirmed by pediatric allergist in two cohorts). Individual estimates of annual average 
air pollution [nitrogen dioxide (NO2), particulate matter ≤ 2.5 μm (PM2.5), PM2.5 absorbance, ozone] 
were assigned to each child’s birth address using land use regression, atmospheric modeling, and ambient 
monitoring data. Effect modification by variants in GSTP1 (rs1138272/Ala114Val and rs1695/IIe105Val) 
and TNF (rs1800629/G-308A) was investigated.
results: Data on asthma, wheeze, potential confounders, at least one SNP of interest, and NO2 were 
available for 5,115 children. GSTP1 rs1138272 and TNF rs1800629 SNPs were associated with asthma 
and wheeze, respectively. In relation to air pollution exposure, children with one or more GSTP1 
rs1138272 minor allele were at increased risk of current asthma [odds ratio (OR) = 2.59; 95% CI: 1.43, 
4.68 per 10 μg/m3 NO2] and ever asthma (OR = 1.64; 95% CI: 1.06, 2.53) compared with homozygous 
major allele carriers (OR = 0.95; 95% CI: 0.68, 1.32 for current and OR = 1.20; 95% CI: 0.98, 1.48 
for ever asthma; Bonferroni-corrected interaction p = 0.04 and 0.01, respectively). Similarly, for GSTP1 
rs1695, associations between NO2 and current and ever asthma had ORs of 1.43 (95% CI: 1.03, 1.98) 
and 1.36 (95% CI: 1.08, 1.70), respectively, for minor allele carriers compared with ORs of 0.82 (95% 
CI: 0.52, 1.32) and 1.12 (95% CI: 0.84, 1.49) for homozygous major allele carriers (Bonferroni-corrected 
interaction p-values 0.48 and 0.09). There were no clear differences by TNF genotype.
conclusions: Children carrying GSTP1 rs1138272 or rs1695 minor alleles may constitute a susceptible 
population at increased risk of asthma associated with air pollution.
citation: MacIntyre EA, Brauer M, Melén E, Bauer CP, Bauer M, Berdel D, Bergström A, 
Brunekreef B, Chan-Yeung M, Klümper C, Fuertes E, Gehring U, Gref A, Heinrich J, Herbarth O, 
Kerkhof M, Koppelman GH, Kozyrskyj AL, Pershagen G, Postma DS, Thiering E, Tiesler CM, 
Carlsten C, TAG Study Group. 2014. GSTP1 and TNF gene variants and associations between air pol-
lution and incident childhood asthma: the traffic, asthma and genetics (TAG) Study. Environ Health 
Perspect 122:418–424; http://dx.doi.org/10.1289/ehp.1307459
Introduction
Evidence supporting an association between 
traffic-related air pollution and incident 
childhood asthma is growing although pub-
lished estimates highlight variability across 
different populations. (Anderson et al. 
2013; Gehring et al. 2010; Nordling et al. 
2008). Genetic variation could be one expla-
nation for this observed heterogeneity and 
gene–environment studies may help identify 
those children most susceptible to air pol-
lution (Bråbäck and Forsberg 2009). Large 
studies that combine multiple birth cohorts 
are ideal for examining gene–environment 
interactions in the development of childhood 
asthma, particularly where there are similar 
assessments of air pollution and asthma across 
cohorts (London 2007).
Genes related to oxidative stress are of spe-
cial interest because of the biological mecha-
nisms thought to underlie both the toxicity of 
traffic-related air pollution and the develop-
ment of asthma (Kelly 2003). GSTP1 (the 
glutathione S-transferase pi gene) codes for 
an enzyme that metabolizes reactive oxygen 
species in the lung, and, despite considerable 
study, associations with atopic disease have not 
been consistent (Piacentini et al. 2013), pos-
sibly because of additional host and environ-
ment factors such as age (Salam et al. 2007). 
To date, GSTP1 polymorphisms have been 
reported to modify the association between 
traffic-related air pollution and allergic sensiti-
zation (Melén et al. 2008), persistent wheeze 
(Schroer et al. 2009), and asthma (Carlsten 
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et al. 2011a) in individual birth cohorts; and 
in one study these strata-specific findings were 
further attenuated by TNF (tumor necrosis 
factor) polymorphisms (Melén et al. 2008). 
TNF mediates inflammation and is expressed 
in response to environmental pollutants (Wu 
et al. 2007). TNF polymorphisms have been 
associated with asthma (Aoki et al. 2006; 
Panasevich et al. 2010) and wheeze (Wu et al. 
2007) and were previously reported to modify 
the association between ozone and asthma in 
healthy young adults (Yang et al. 2008).
We initiated an international collabora-
tion, the Traffic, Asthma and Genetics Study 
(TAG), to examine the influence of specific 
candidate genes on the relationship between 
traffic-related air pollution and the develop-
ment of childhood asthma.
Methods
The Canadian Asthma Primary Prevention 
Study (CAPPS) is a randomized controlled 
study of high-risk children (Carlsten et al. 
2011b). The Study of Asthma, Genes and 
the Environment (SAGE) is a Canadian 
population-based birth cohort (Kozyrskyj 
et al. 2009). The Children, Allergy, Milieu, 
Stockholm, Epidemiological Survey (BAMSE) 
is a population-based Swedish birth cohort 
(Melén et al. 2008). The German Infant 
Nutrition Intervention Study plus environ-
mental and genetic influences on allergy 
(GINI) is a population-based birth cohort 
(Morgenstern et al. 2008). The Influence of 
Life-Style Factors on the Development of the 
Immune System and Allergies in East and 
West Germany plus the influence of traf-
fic emissions and genetics (LISA) study is a 
population-based birth cohort (Morgenstern 
et al. 2008). The Prevention and Incidence of 
Asthma and Mite Allergy (PIAMA) study is 
a population-based birth cohort (Brunekreef 
et al. 2002). Detailed cohort descriptions 
are provided in the Supplemental Material, 
Appendix 1, and additional details on the 
TAG study have been previously published 
(MacIntyre et al. 2013). Parents participating 
in each cohort provided informed consent, 
and protocols were approved by all relevant 
ethical review boards.
Physician-diagnosed asthma and wheeze 
symptoms were collected from parental ques-
tionnaires. CAPPS and SAGE children were 
also evaluated by a pediatric allergist to con-
firm asthma. Current asthma and current 
wheeze were ascertained at 8 years (6 years 
for GINI/LISA wheeze; 7 years for CAPPS 
asthma/wheeze). Ever asthma and ever wheeze 
were defined using every available  follow-up to 
8 years. Children missing ≥ 2 follow-ups were 
excluded. Data were collected at slightly differ-
ent time points, and there were minor differ-
ences in question wording across the cohorts 
(MacIntyre et al. 2013).
Annual average nitrogen dioxide (NO2) 
was estimated using traffic-related land use 
regression (LUR) models, except for the 
BAMSE cohort, which used dispersion mod-
eling (Bellander et al. 2001). LUR models 
developed for PIAMA and LISA/GINI 
Munich (Germany) were based on data col-
lected in 1999–2000 (Brauer et al. 2003), 
LISA/GINI Wesel (Germany) in 2003, LISA/
GINI Leipzig (Germany) in 2004/2005 
(Hochadel et al. 2006), CAPPS Vancouver 
(BC, Canada) in 2003 (Henderson et al. 
2007), and SAGE and CAPPS Winnipeg 
(MB, Canada) in 2007 (Allen et al. 2010). 
For all study sites, integrated 14-day sampling 
campaigns were repeated over a 12-month 
period to capture seasonal patterns in air pol-
lution. Protocols were specifically developed 
to spatially model long-term average pollut-
ant concentrations. Potential predictors for 
traffic were screened based on their correla-
tion with measured pollutants. Final mod-
els were assessed based on the coefficient of 
determination and root mean square error 
from cross-validation. LUR estimated PM2.5 
(particulate matter with diameter ≤ 2.5 μm) 
and PM2.5 absorbance (a measure of elemen-
tal carbon estimated from filter reflectance 
measurements) were available for a subset of 
the combined cohort. For BAMSE, emis-
sion data for traffic-generated nitrogen oxides 
(NOx) were collected for the years 1990 and 
2000; and dispersion was estimated using a 
dilution model based on wind speed, direc-
tion, and precipitation (Nordling et al. 2008). 
Additionally, ozone was estimated for the 
European cohorts using APMoSPHERE (Air 
Pollution Modelling for Support to Policy on 
Health and Environmental Risk in Europe) 
(Beelen et al. 2009), and for CAPPS/SAGE 
using inverse distance weighting of the closest 
three ambient monitors (within 50 km). NO2 
was the only air pollution metric that was 
available across all six cohorts. PM2.5, PM2.5 
absorbance, and ozone were used in sensi-
tivity analyses because estimates of exposure 
to these pollutants were not available for all 
cohorts. Exposures were assigned for the first 
year of life based on geocoded birth addresses.
Candidate genes were selected based on 
availability of data across all six cohorts. The 
following single-nucleotide polymorphisms 
(SNPs) were investigated: GSTP1 rs1138272 
(merged with rs1799811; C→T: Ala114Val), 
GSTP1 rs1695 (merged with rs947894; A→G: 
Ile105Val), and TNF rs1800629 (G→A: –308). 
Genotypic analyses were conducted at sepa-
rate facilities using a variety of methods: The 
Canadian birth cohorts both used the Illumina 
BeadArray system (Illumina, San Diego, CA, 
USA) following the manufacturer’s protocol 
[CAPPS: peripheral blood was collected at 
7 years (Carlsten et al. 2011a); SAGE: buccal 
samples were collected at 9 years (Kozyrskyj 
et al. 2009)]. The PIAMA study collected 
buccal swabs or blood at 4–8 years and used 
Competitive Allele-Specific PCR (polymerase 
chain reaction) using KASParTM genotyping 
chemistry (KBiosciences, Hoddesdon, UK). 
(Koopman et al. 2002). The German studies 
and BAMSE used matrix-assisted laser desorp-
tion/ionization–time of flight (MALDI-TOF) 
mass spectrometry (Sequenom, San Diego, 
CA, USA) following the manufacturer’s proto-
col [GINI/LISA: blood samples were collected 
at 6–10 years; BAMSE: blood samples were 
collected at 4 years (Melén et al. 2008)]. The 
German studies additionally used the restric-
tion fragment length polymorphism approach 
for GSTP1 rs1695 (Slama et al. 2010) and 
high-resolution melting-PCR using LightSNiP 
hybridization probe for GSTP1 rs1138272 
(TIB MolBiol, Berlin, Germany).
Data transfer and harmonization occurred 
in several stages. First, each cohort sent data 
dictionaries (translated to English, where 
applicable) to the main study center at the 
University of British Columbia. From each of 
the data dictionaries, a list of key variables was 
compiled and sent to each cohort to request 
data extraction. Data extracts were then pre-
pared by each cohort and sent to the main 
study center for harmonization and merging. 
Data were collected at different time points 
across the cohorts, with differences in ques-
tionnaire wording and case definitions [see 
MacIntyre et al. (2013) for additional infor-
mation]. In the pooled data set, new vari-
ables for this analysis were derived from data 
 common to all cohorts.
Statistical analysis. We examined the 
main effect estimate for each SNP using 
dominant genetic models. Effect modifica-
tion was examined in adjusted analyses of 
NO2 (per 10-μg/m3 increase) and asthma/
wheeze, stratified by genotype. Interactions 
between genotype and NO2 were investi-
gated using the log likelihood ratio for mod-
els with and without product interaction 
terms. Models were adjusted for potential 
confounders available across each cohort: 
study, city, infant sex, birth weight (< 2,500, 
2,500–4,000, > 4,000 g), parental history of 
allergy (yes/no), maternal age at birth (≤ 24, 
25–29, 30–34, ≥ 35 years), maternal smoking 
reported anytime during pregnancy (yes/no), 
environmental tobacco smoke reported in the 
home (yes/no), and intervention (yes/no). All 
pooled analyses used weighted logistic regres-
sion to adjust for inclusion of case–control 
data (Richardson et al. 2007). Sensitivity 
analyses investigated additional exposure 
metrics available for only a subset of pooled 
data [PM2.5 (per 4-μg/m3 increase), PM2.5 
absorbance (per 0.5 10–5/m increase), and 
ozone (per 10-μg/m3 increase)). All p-values 
were corrected for multiple testing using 
Bonferroni adjustment, and adjusted p-values 
MacIntyre et al.
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< 0.05 were considered statistically signifi-
cant. All analyses used SAS version 9.2 (SAS 
Institute Inc., Cary, NC, USA).
Results
Table 1 describes the population character-
istics for children included in at least one 
analyses (Ntotal = 5,115). The population 
used for TAG had a lower prevalence of low 
birth weight (< 2,500 g) babies (3% vs. 12%), 
fewer mothers < 25 years of age (6% vs. 9%), 
more parents with reported atopy (55% vs. 
47%), and fewer mothers who smoked during 
pregnancy (14% vs. 17%), compared to the 
total recruited population for each cohort.
A total of 5,115 children had complete 
data on asthma, wheeze, potential confound-
ers, NO2, and at least one SNP (4,596 with 
GSTP1 rs1138272, 4,748 with GSTP1 
rs1695, 4,483 with TNF rs1800629); 22% 
were part of an intervention, 52% were male, 
29% were exposed to environmental tobacco 
smoke in the home, 55% had parental his-
tory of atopy, and 19% were born to moth-
ers ≥ 35 years of age. Parents of 7.5% of the 
children reported current asthma (ranging 
from 2.3% to 40.5% in individual cohorts), 
18% reported ever asthma (4.6–41.6%), 
12.5% reported current wheeze (7.0–69.0%), 
45% ever wheeze (35.2–69.0%), and 7.6% 
reported both ever asthma and current 
wheeze (“active asthma”; 2.8–46.6%).
Table 2 describes pollutant distributions 
for NO2, PM2.5, PM2.5 absorbance, and 
ozone. Data are presented for the pooled data 
set and by cohort or combinations of cohorts 
in which an identical LUR model was used in 
two different cohorts (Munich, Wesel, and 
Winnipeg). In general, the mean NO2 con-
centrations for Germany and the Netherlands 
were similar, whereas those for one of the 
Canadian locations (Winnipeg) and Sweden 
were lower. For the 2,743 children in sensitiv-
ity analyses, NO2 was correlated with PM2.5 
absorbance (r = 0.72), weakly correlated with 
PM2.5 (r = 0.23), and inversely correlated 
with ozone (r = –0.19). The inverse correla-
tion between NO2 and ozone was attributable 
to the atmospheric chemistry unique to each 
pollutant; and the weak correlation between 
PM2.5 and PM2.5 absorbance was likely 
attributable to differences in the composition 
and sources of air pollution in each region.
The population distribution and number 
of asthma cases by genotype are presented in 
Table 3. All SNPs satisfied Hardy–Weinberg 
equilibrium based on chi-square statistics 
(p < 0.05).
Main effect estimates. Table 4 shows the 
main effect estimates for associations of the 
genotypes and air pollution exposures with 
the respiratory outcomes based on the pooled 
data for all cohorts combined. Effect estimates 
were calculated for homozygous and hetero-
zygous minor allele carriers versus homo-
zygous major allele carriers. The adjusted 
Table 1. Population characteristics for the pooled TAG data set and for each individual cohort [n (%)].
Characteristic Pooled BAMSE CAPPS GINI LISA SAGE PIAMA
Total population 5,115 (100) 912 (100) 346 (100) 1,126 (100) 697 (100) 178 (100) 1,856 (100)
Intervention 1,114 (21.8) NA 181 (52.3) 528 (46.9) NA NA 405 (21.8)
Male sex 2,661 (52.0) 484 (53.1) 189 (54.6) 584 (51.9) 361 (51.8) 96 (53.9) 947 (51.0)
Birth weight (g)
< 2,500  150 (2.9) 45 (4.9) 16 (4.6) 19 (1.7) 0 (–) 13 (7.3) 57 (3.1)
2,500–4,000  4,085 (79.9) 706 (77.4) 256 (74.0) 952 (84.6) 587 (84.2) 132 (74.2) 1,452 (78.2)
> 4,000  880 (17.2) 161 (17.6) 74 (21.4) 155 (13.8) 110 (15.8) 33 (18.5) 347 (18.7)
Maternal smoking during pregnancy 688 (14.1) 119 (13.1) 29 (8.4) 149 (15.7) 91 (13.6) 18 (10.2) 282 (15.3)
Environmental tobacco smoke at homea 1,465 (28.6) 164 (18.0) 71 (20.5) 315 (28.0) 158 (22.7) 34 (19.1) 723 (39.0)
Parental atopy 2,802 (54.8) 530 (58.1) 319 (92.2) 459 (40.8) 348 (49.9) 126 (70.8) 1,020 (55.0)
Mother’s age at birth (years)
≤ 24 285 (5.6) 73 (8.0) 23 (6.7) 44 (3.9) 38 (5.5) 22 (12.4) 85 (4.5)
25–29 1,574 (30.8) 287 (31.5) 86 (24.9) 314 (27.9) 221 (31.7) 54 (30.3) 612 (33.0)
30–34 2,278 (44.5) 363 (40.2) 125 (36.1) 553 (49.1) 306 (44.1) 74 (41.6) 857 (46.2)
≥ 35 978 (19.1) 189 (20.7) 112 (32.4) 215 (19.1) 132 (18.9) 28 (15.7) 302 (16.3)
Current asthma 381 (7.5) 112 (12.3) 62 (17.9) 42 (3.7) 16 (2.3) 72 (40.5) 77 (4.2)
Ever asthma 878 (17.7) 272 (29.8) 144 (41.6) 86 (8.2) 30 (4.6) 72 (40.5) 274 (15.0)
Current wheeze 623 (12.5) 162 (17.9) 76 (22.0) 112 (10.1) 63 (9.4) 80 (69.0) 130 (7.0)
Ever wheeze 2,243 (44.9) 535 (58.7) 159 (46.0) 383 (35.2) 278 (40.0) 80 (69.0) 808 (44.0)
Ever asthma AND current wheeze 372 (7.6) 122 (13.5) 61 (17.3) 41 (3.9) 18 (2.8) 54 (46.6) 76 (4.2)
NA, not applicable.
aDefined as one or more person in the household regularly smoking indoors during the first year of life (exceptions: second year of life in GINI; eighth year of life in SAGE). 
Table 2. Annual average pollutant statistics for the first year of life for pooled data and for each individual model.
Statistic Pooled data Sweden (BAMSE)
Munich, Germany 
(LISA/GINI)









Mean ± SD 22.7 ± 8.1 16.7 ± 9.1 27.5 ± 6.3 22.9 ± 3.5 24.6 ± 7.4 32.5 ± 6.0 12.2 ± 3.6
IQR 10.3 13.8 8.1 4.9 11.2 7.1 5.2
Range 2.2–66.8 2.2–49.9 19.5–66.9 13.9–41.4 12.6–58.4 18.9–55.1 4.1–21.5
Ozone (μg/m3)
Mean ± SD 36.8 ± 6.5 NA 43.9 ± 2.1 39.4 ± 3.6 33.8 ± 4.7 21.2 ± 2.8 NA
IQR 9.1 NA 1.0 6.9 4.3 4.8 NA
Range 13.3–55.9 NA 38.8–55.9 32.3–48.6 13.3–47.3 13.4–27.0 NA
PM2.5 (μg/m3)
Mean ± SD 15.2 ± 3.4 NA 13.3 ± 1.3 NA 16.7 ± 1.9 5.6 ± 2.6 NA
IQR 4.1 NA 1.5 NA 3.4 3.9 NA
Range 0.0–25.1 NA 11.9–21.9 NA 13.5–25.2 0.0–10.0 NA
PM2.5 absorbance (10–5/m)
Mean ± SD 1.7 ± 0.4 NA 1.7 ± 0.3 1.6 ± 0.2 1.7 ± 0.4 1.6 ± 1.2 NA
IQR 0.4 NA 0.3 0.2 0.6 1.1 NA
Range 0.0–5.0 NA 1.4–4.3 0.8–2.3 0.8–3.7 0.0–5.0 NA
Abbreviations: IQR, interquartile range; NA, not applicable.
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odds ratio (OR) for GSTP1 rs1138272 and 
current asthma was 1.57 (95% CI: 1.16, 
2.14; Bonferroni-corrected p-value = 0.012). 
Findings were similar for GSTP1 rs1138272 
and ever asthma (OR = 1.49; 95% CI: 1.20, 
1.84; corrected p-value < 0.001) and current 
wheeze plus ever asthma (OR = 1.61; 95% 
CI: 1.22, 2.14; corrected p-value = 0.003). 
The adjusted OR for GSTP1 rs1695 and cur-
rent asthma was 0.87 (95% CI: 0.68, 1.12) 
in pooled analysis; associations between 
rs1695 and remaining respiratory outcomes 
were consistent with the null hypothesis. 
The adjusted OR for TNF rs1800629 and 
current asthma was 1.20 (95% CI: 0.92, 
1.57). The association between ever wheeze 
and TNF rs1800629 was not statistically sig-
nificant after adjusting for multiple testing 
(OR = 1.18; 95% CI: 1.02, 1.37; corrected 
p-value = 0.087). Statistically significant asso-
ciations were estimated for NO2 and ever 
asthma (OR = 1.23; 95% CI: 1.03–1.46 
per 10-μg/m3 increase; corrected p-value = 
0.019) and for PM2.5 and current asthma 
(OR = 2.08; 95% CI: 1.35–3.19 per 4-μg/m3 
increase; corrected p-value = 0.001).
Genotype stratification and interaction. 
The associations between NO2 during the 
first year of life and respiratory outcomes, 
stratified by genotype, and interaction 
p-values are presented in Table 5 for pooled 
data. Effect estimates were elevated and statis-
tically significant in carriers of minor alleles of 
GSTP1 rs1138272 and rs1695 in models for 
current asthma (corrected p-value for minor 
allele carriers = 0.006; corrected p-value for 
homozygous major allele carriers = 0.766; 
corrected p-values for interaction = 0.039) 
and ever asthma (corrected p-value for minor 
allele carriers = 0.048; corrected p-value for 
homozygous major allele carriers = 0.432; 
corrected p-values for interaction = 0.087), 
respectively. Overall, effect estimates were 
greater for minor allele carriers than for their 
respective homozygous major allele carriers in 
models for current asthma and ever asthma. 
Findings for TNF generally supported the 
null hypothesis.
For children who were minor allele car-
riers for both GSTP1 SNPs (rs1138272 and 
rs1695; Ntotal = 728) there were statistically 
significant associations between NO2 and 
current asthma (OR = 2.37; 95% CI: 1.31, 
Table 3. Population distribution by minor allele carriers and homozygous major allele carriers for GSTP1 
and TNF (pooled data).




in the highest tertile  
of NO2 (n)
Children with current asthma 
in the highest tertile 
of NO2 [n (%)]
GSTP1 rs1138272
TT/TC 789 80 (10.1) 224 15 (6.7)
CC 3,807 287 (7.5) 1,144 57 (5.0)
GSTP1 rs1695
GG/GA 2,740 199 (7.3) 873 34 (3.9)
AA 2,008 170 (8.5) 618 39 (6.3)
TNF rs1800629
AA/AG 1,411 119 (8.4) 421 31 (7.4)
GG 3,072 244 (7.9) 917 40 (4.4)
Table 4. Main genetic and environmental effect estimates for GSTP1, TNF, and NO2 for asthma and wheeze at school age (pooled data).
SNP, exposure
Current asthma Ever asthma Current wheeze Ever wheeze Ever asthma and current wheeze
n aORa (95% CI) pb n aORa (95% CI) pb n aORa (95% CI) pb n aORa (95% CI) pb n aORa (95% CI) pb
GSTP1 rs1138272 TT/TC v. CC 4,596 1.57 
(1.16, 2.14)
0.012 4,465 1.49 
(1.20, 1.84)
< 0.001 4,483 1.15 
(0.84, 1.57)
0.560 4,487 1.01 
(0.84, 1.22)
0.918 4,377 1.61 (1.22, 2.14) 0.003
GSTP1 rs1695 GG/GA v. AA 4,748 0.87 
(0.68, 1.12)
0.285 4,635 0.91 
(0.77, 1.08)
0.430 4,659 1.02 
(0.81, 1.29)
0.860 4,633 0.96 
(0.83, 1.10)
0.803 4,547 0.94 (0.75, 1.19) 0.628
TNF rs1800629 AA/AG v. GG 4,483 1.20 
(0.92, 1.57)
0.258 4,356 1.04 
(0.87, 1.26)
0.647 4,371 1.22 
(0.95, 1.56)
0.345 4,373 1.18 
(1.02, 1.37)
0.087 4,267 1.10 (0.85, 1.41) 0.628




0.322 4,965 1.23 
(1.03, 1.46)
0.019 4,999 1.12 
(0.89, 1.40)
0.337 4,995 1.04 
(0.91, 1.18)
0.610 4,874 1.13 (0.87, 1.46) 0.374
Ozone (per 10-μg/m3 increase) 2,743 0.81 
(0.51, 1.27)
0.351 2,671 0.86 
(0.66, 1.13)
0.277 2,728 1.29 
(0.88, 1.88)
0.197 2,704 0.90 
(0.74, 1.10)
0.318 2,659 1.01 (0.62, 1.67) 0.960




0.001 2,671 1.17 
(0.86, 1.60)
0.323 2,728 1.33 
(0.90, 1.95)
0.147 2,704 0.95 
(0.74, 1.22)
0.687 2,659 1.46 (0.93, 2.32) 0.102
Traffic-related PM2.5 absorbance 
(per 0.5 10–5/m increase)
2,743 1.07 
(0.91, 1.26)
0.441 2,671 1.06 
(0.95, 1.19)
0.283 2,728 1.06 
(0.93, 1.21)
0.395 2,704 1.00 
(0.91, 1.10)
0.963 2,659 1.07 (0.92, 1.25) 0.369
aOR, adjusted odds ratio.
aAdjusted for study, city, intervention, infant sex, maternal age at birth, maternal smoking during pregnancy, environmental tobacco smoke in the home, birth weight, and parental 
atopy. bp-Values were corrected for multiple testing using the Bonferroni method.
Table 5. Association between traffic-related NO2 during the first year of life and asthma and wheeze at school age (pooled data).
Gene
Current asthma Ever asthma Current wheeze Ever wheeze Ever asthma and current wheeze
n aORa (95% CI) pb n aORa (95% CI) pb n aORa (95% CI) pb n aORa (95% CI) pb n aORa (95% CI) pb
GSTP1 rs1138272
TT/TC 789 2.59 (1.43, 4.68) 0.006 769 1.64 (1.06, 2.53) 0.075 772 1.26 (0.71, 2.23) 0.821 775 1.17 (0.82, 1.65) 0.467 757 1.30 (0.67, 2.52) 0.669
CC 3,807 0.95 (0.68, 1.32) 0.766 3,696 1.20 (0.98, 1.48) 0.140 3,711 1.09 (0.82, 1.45) 0.821 3,712 1.09 (0.92, 1.29) 0.467 3,620 1.17 (0.85, 1.61) 0.669
Interactionc 0.039 0.012 0.096 0.024 0.180
GSTP1 rs1695
GG/GA 2,704 1.43 (1.03, 1.98) 0.096 2,677 1.36 (1.08, 1.70) 0.048 2,695 1.18 (0.86, 1.60) 0.821 2,692 1.11 (0.93, 1.33) 0.467 2,632 1.16 (0.82, 1.65) 0.669
AA 2,008 0.82 (0.52, 1.32) 0.626 1,958 1.12 (0.84, 1.49) 0.432 1,964 1.03 (0.72, 1.46) 0.888 1,951 0.98 (0.79, 1.23) 0.886 1,915 1.09 (0.70, 1.68) 0.709
Interactionc 0.484 0.087 0.187 0.026 0.436
TNF rs1800629
AA/AG 1,411 1.30 (0.85, 2.00) 0.448 1,372 1.29 (0.94, 1.78) 0.143 1,383 1.04 (0.68, 1.59) 0.888 1,384 1.14 (0.86, 1.49) 0.467 1,350 1.13 (0.70, 1.82) 0.709
GG 3,072 1.07 (0.72, 1.57) 0.766 2,984 1.21 (0.97, 1.52) 0.140 2,988 1.24 (0.92, 1.68) 0.821 2,989 1.09 (0.91, 1.30) 0.467 2,917 1.15 (0.81, 1.63) 0.669
Interactionc 0.210 0.345 0.096 0.337 0.436
aOR, adjusted odds ratio.
aFor a 10-μg/m3 increase in NO2. Adjusted for study, city, intervention, infant sex, maternal age at birth, maternal smoking during pregnancy, environmental tobacco smoke in the home, birth weight, 
and parental atopy. bp-Values were corrected for multiple testing using the Bonferroni method. cp-Values for interaction were calculated based on the likelihood-ratio tests between models with 
and without interaction terms and were corrected for multiple testing using the Bonferroni method. 
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4.34 per 10 μg/m3 NO2; p = 0.005) and ever 
asthma (OR = 1.57; 95% CI: 1.04, 2.37; 
p = 0.032); analyses in remaining GSTP1 
rs1138272*rs1695 strata (rs1138272 TT/TC 
and rs1695 AA; rs1138272 CC and rs1695 
GG/GA; rs1138272 CC and rs1695 AA) 
were nonsignificant (data not shown).
Sensitivity analyses. Sensitivity analyses 
are presented in the Supplemental Material, 
Tables S1–S12. The following cohorts (or 
cohort subsets) had assigned ozone, PM2.5, 
and PM2.5 absorbance; CAPPS Vancouver, 
LISA, GINI, and PIAMA. A total of 2,743 
children had complete data on asthma, 
wheeze, potential confounders, NO2, ozone, 
PM2.5, PM2.5 absorbance, and at least one 
SNP of interest (n = 2,367 with GSTP1 
rs1138272; n = 2,559 with GSTP1 rs1695; 
n = 2,318 with TNF rs1800629). Pooled 
estimates were recalculated for these addi-
tional air pollution metrics (see Supplemental 
Material, Tables S1–S3, respectively). In 
analyses stratified by genotype, there was 
an association between ozone and current 
wheeze (OR = 3.67; 95% CI: 1.05, 12.7; 
Ntotal = 405) in GSTP1 rs1138272 minor 
allele carriers, and between PM2.5 and cur-
rent asthma in all strata examined, although 
small sample size for some strata resulted in 
highly imprecise estimates. The results of 
multipollutant models examining NO2 and 
PM2.5, stratified by genotype, are presented 
in Supplemental Material, Table S4. NO2 
effect estimates were sensitive to inclusion 
of PM2.5 in some analyses, but these results 
should be interpreted cautiously because data 
were  available for only four cohorts.
The analyses applied to the pooled data 
were also applied to each individual cohort 
(see Supplemental Material, Tables S5–S10). 
Results showed some heterogeneity in the 
magnitude of effect estimate, but findings 
were generally not statistically significant due 
to small sample sizes. For example, the odds 
of current asthma per 10 μg/m3 NO2 for 
GSTP1 rs1138272 minor allele carriers were 
2.19 (0.54, 8.86) in BAMSE, 6.33 (95% CI: 
0.66, 60.8) in GINI and LISA Munich, 
5.44 (95% CI: 1.23, 24.0) in GINI and 
LISA Wesel, 2.27 (95% CI: 0.69, 7.49) in 
PIAMA, 2.30 (95% CI: 0.02, 256) in CAPPS 
Vancouver, and 19.20 (95% CI: 0.79, 466) 
in CAPPS and SAGE Winnipeg, versus 2.59 
(95% CI: 1.43, 4.68) in pooled data. Further, 
the interactions between NO2 and genotype 
in pooled analyses were robust in reanalyses 
that sequentially excluded individual cohorts 
(data not shown).
Finally, analyses were rerun after restricting 
the pooled cohort to only those children in 
an observational (nonintervention) study arm 
(Ntotal = 3,695; see Supplemental Material, 
Table S11) and to children of Caucasian race 
(Ntotal = 4,821; see Supplemental Material, 
Table S12; data available only for CAPPS 
and SAGE). Results of these final sensitivities 
were in general agreement with findings in the 
full data set.
Discussion
This study is the first Canadian–European 
consortium to examine the interaction 
between traffic-related air pollution and can-
didate genes of oxidative stress and inflam-
mation in the development of childhood 
asthma. The pooled data set included 381 
children with current asthma and 878 with 
ever asthma, and provided an unprecedented 
opportunity to identify populations geneti-
cally at risk for asthma development in rela-
tion to traffic-related air pollution. Our 
findings suggest that children with variant 
GSTP1 genotypes may constitute a suscep-
tible population at increased risk of asthma 
associated with air pollution.
The purpose of this work was to estimate 
the effect of two oxidative stress and inflam-
mation genes on the relationship between 
traffic-related air pollution and the develop-
ment of asthma in childhood. Asthma was 
associated with GSTP1 rs1138272 in the 
study population. In analyses of NO2 and 
respiratory outcome, stratified by genotype, 
minor allele carriers for GSTP1 rs1138272 
and GSTP1 rs1695 appeared to be more sus-
ceptible to the harmful effects of air pollution 
than their homozygous major allele–carry-
ing counterparts. The interaction between 
GSTP1 rs1138272 and NO2 was statistically 
significant in models for current asthma, ever 
asthma, and ever wheeze.
In this study we used data from six birth 
cohorts. Five of these cohorts have previ-
ously reported associations between traffic-
related air pollution and respiratory outcomes 
during childhood (Carlsten et al. 2011b; 
Gehring et al. 2010; Morgenstern et al. 2008; 
Nordling et al. 2008); and three have pre-
viously reported gene–air pollution interac-
tions in the development of childhood asthma 
(Carlsten et al. 2011a; Melén et al. 2008; 
Nordling et al. 2008). The BAMSE cohort 
reported a statistically significant association 
between NOx and asthma at 4 years of age in 
children who were both minor allele carriers 
for GSTP1 rs1695 and homozygous major 
allele carriers for TNF rs1800629 (OR = 2.9; 
95% CI: 1.0–8.2 for a 44-μg/m3 increase in 
NOx) (Melén et al. 2008). We did not find 
strong evidence for a gene–gene–environment 
interaction in the pooled data set, although 
effect estimates were similar to those reported 
by Melén et al. (2008). The CAPPS study, 
which was particularly limited by sample size 
and did not have any homozygous minor 
allele carriers for GSTP1 rs1138272, reported 
a negative but not statistically significant asso-
ciation between NO2 and asthma at 7 years 
of age in children who were heterozygous 
for GSTP1 rs1138272 (OR = 0.76; 95% CI: 
0.18–3.30 for a 7.2-μg/m3 increase in NO2; 
NTotal = 25) (Carlsten et al. 2011a). Finally, 
the PIAMA study has previously reported 
effect modification by interaction analyses 
for multiple TLR2 and TLR4 SNPs in the 
association between air pollution (using the 
same LUR models we presented) and child-
hood asthma in a subset of the PIAMA 
cohort (NTotal = 916; Kerkhof et al. 2010); 
but the current study is the first examination 
of GSTP1 and TNF.
Polymorphisms in genes related to oxi-
dative stress (NQO1, GSTM1, and GSTP1) 
have been associated with increased risk of 
asthma. Previous work has reported reduc-
tions in GSTP1 expression among rs1138272 
and rs1695 minor allele carriers (Moyer et al. 
2008). Minor allele carriers of rs1695 were 
found to be at increased risk for asthma in 
numerous different study populations (Tamer 
et al. 2004), particularly when children were 
exposed to environmental tobacco smoke 
(Palmer et al. 2006) or living in regions with 
high air pollution (Romieu et al. 2006); 
and impaired lung function was observed in 
schoolchildren living in areas of high urban 
air pollution (Reddy et al. 2012). It has also 
been suggested that GST genes may modify 
the lung response after co-exposure to die-
sel exhaust and allergen (Gilliland 2009). 
Conversely, the rs1695 SNP has been neg-
atively associated with asthma (Aynacioglu 
et al. 2004; Fryer et al. 2000) and was associ-
ated with a lower risk of incident asthma with 
exercise in communities with high (vs. low) 
levels of ozone (Islam et al. 2009). Few studies 
have had the opportunity to evaluate GSTP1 
rs1138272 and air pollution, partly because of 
the low frequency of minor allele carriers.
The inflammatory response gene TNF 
(rs1800629) has been reported to modify the 
relationship between ozone and asthma (Yang 
et al. 2008) and indoor home dampness and 
asthma (Tsai et al. 2011); however, similar to 
our results, no effect modification was noted 
in the association between traffic-related 
NO2 and adult-onset asthma (Castro-Giner 
et al. 2009).
In the present study we pooled data 
across six cohorts; but unfortunately, of the 
many SNPs associated with oxidative stress 
and inflammation, only three were typed 
across all cohorts. It is possible that this study 
was underpowered; however, homozygous 
and heterozygous minor allele carriers were 
combined into one category for all analy-
ses (Melén et al. 2008; Salam et al. 2007), 
and three of the TAG cohorts intentionally 
increased the proportion of children with 
asthma or wheeze through study design.
NO2 is especially useful as a marker 
of within-city variability in exposure to 
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traffic-related pollution and has been used 
as a marker of traffic pollution exposure in 
previous epidemiological investigations 
(Brunekreef 2007; Clark et al. 2010; Emenius 
et al. 2003; Gehring et al. 2010). Our 
results were not fully replicated in the subset 
(n = 2,743) of children with available data on 
additional markers of traffic-related (PM2.5 
and PM2.5 absorbance) and regional (ozone) 
air pollution. The air pollution metrics exam-
ined here were considered only as markers for 
traffic-related air pollution; and the goal of 
this work was not to highlight the importance 
of one metric over another, but instead to 
highlight the significant potential impact of 
this air pollution source.
The TAG cohorts are unique in that they 
have individually assigned exposures with 
high spatial resolution for the first year of life 
based on residential address at birth—thus 
capturing the important exposure window 
during early life (Clark et al. 2010; Gehring 
et al. 2010). Although measurements for the 
LUR models were not originally taken during 
the first year of life, detailed investigations, 
including two conducted in our study areas, 
found the spatial distribution of traffic-related 
pollutants to be stable for up to 12 years 
(Eeftens et al. 2011; Gulliver et al. 2013; 
Wang et al. 2012). LUR model estimates 
were temporally adjusted using fixed-site 
monitoring data collected during the actual 
first year of life for cohorts that completed 
NO2 monitoring campaigns > 8 years after 
the birth year (CAPPS and SAGE).
An additional strength of the cohorts 
we included is that each recruited pregnant 
women or newborns and was therefore able 
to assess the development of asthma from 
birth. Ascertainment of physician-diagnosed 
asthma and wheeze symptoms via parental 
questionnaire is reasonably accurate (Burr 
1992), particularly in countries with universal 
health care, where lack of insurance does not 
hinder access to health care. Further, the two 
cohorts with the highest prevalence of asthma 
(SAGE and CAPPS) also completed exam-
inations by a pediatric allergist to confirm 
parent-reported asthma diagnoses. Further, 
although there were slight differences in ques-
tionnaire wording for asthma and predictors 
for air pollutant models, the general consis-
tency in effect estimate direction and mag-
nitude across analyses stratified by cohort or 
land use regression model (see Supplemental 
Material, Tables S5–S10) is reassuring and 
further  supports our findings.
The findings presented here may have 
been confounded by exposures associated with 
oxidative stress or airway inflammation. We 
adjusted for environmental tobacco smoke 
and parental history of asthma or atopic dis-
ease, but it was not possible to adjust pooled 
analyses for the presence of allergens in the 
home or ethnicity. Smoking was associated 
with increased odds of disease in all pooled 
analyses; however, this finding was statisti-
cally significant only for “ever asthma” (data 
not shown). Sensitivity analyses excluding 
non-Caucasian children from the Canadian 
cohorts (< 80% Caucasian) were completed 
to ensure that our findings were not influ-
enced by the ethnic composition of our 
population (Spielman et al. 2007); the propor-
tion of Caucasian children in the European 
cohorts was very high (98%) and they were 
not restricted in the sensitivity. Finally, addi-
tional sensitivity analyses excluding children 
assigned to an intervention (Supplemental 
Material, Table S11; CAPPS, GINI, and 
PIAMA) were completed to ensure that our 
findings were not affected by preventive mea-
sures; this is particularly important because the 
CAPPS study has reported a protective effect 
(for children assigned to the intervention) on 
the development of childhood asthma up to 
7 years of age (Chan-Yeung et al. 2000).
Our findings add to previous research by 
providing further insight into the complex 
relationship between genetics and environ-
mental factors in the development of child-
hood asthma. We found the association 
between traffic-related air pollution and the 
development of childhood asthma to be influ-
enced somewhat by GSTP1 polymorphisms 
(rs1138272 and rs1695), and these findings 
support the hypothesis that the oxidative stress 
response is important in the pathogenesis of 
childhood asthma, particularly in the pres-
ence of air pollution. We found no indication 
of effect modification by the inflammatory 
response gene TNF (rs1800629) on the asso-
ciation between traffic-related air pollution 
and childhood asthma. GSTP1 (rs1138272 
and rs1695) minor allele carriers may be a sus-
ceptible population at increased risk of asthma 
in association with air pollution.
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